Cargando…
Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation
BACKGROUND: Cystic fibrosis (CF) continues to be the most common life-limiting chronic pulmonary disease in adolescents and young adults. Treatment of CF demands a high treatment time investment to slow the progression of lung function decline, the most important contributor to morbidity and mortali...
Autores principales: | Rudolf, Isa, Pieper, Katharina, Nolte, Helga, Junge, Sibylle, Dopfer, Christian, Sauer-Heilborn, Annette, Ringshausen, Felix C, Tümmler, Burkhard, von Jan, Ute, Albrecht, Urs-Vito, Fuge, Jan, Hansen, Gesine, Dittrich, Anna-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895868/ https://www.ncbi.nlm.nih.gov/pubmed/31750841 http://dx.doi.org/10.2196/12442 |
Ejemplares similares
-
Changes in cystic fibrosis transmembrane conductance regulator protein expression prior to and during elexacaftor-tezacaftor-ivacaftor therapy
por: Stanke, Frauke, et al.
Publicado: (2023) -
Spirometric and anthropometric improvements in response to elexacaftor/tezacaftor/ivacaftor depending on age and lung disease severity
por: Schütz, Katharina, et al.
Publicado: (2023) -
Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test
por: Minso, Rebecca, et al.
Publicado: (2020) -
Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study
por: Dettmer, Sabine, et al.
Publicado: (2023) -
The human respiratory tract microbial community structures in healthy and cystic fibrosis infants
por: Pust, Marie-Madlen, et al.
Publicado: (2020)